IFN-λ therapy prevents severe gastrointestinal graft-versus-host disease.
Henden AS, Koyama M, Robb RJ, Forero A, Kuns RD, Chang K, Ensbey KS, Varelias A, Kazakoff SH, Waddell N, Clouston AD, Giri R, Begun J, Blazar BR, Degli-Esposti MA, Kotenko SV, Lane SW, Bowerman KL, Savan R, Hugenholtz P, Gartlan KH, Hill GR.
Henden AS, et al. Among authors: robb rj.
Blood. 2021 Aug 26;138(8):722-737. doi: 10.1182/blood.2020006375.
Blood. 2021.
PMID: 34436524
Free PMC article.